Description: Biotech Acquisition Company is a blank check company. The Company is created for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or other similar business combination with one or more businesses. The Company focuses for a target business in the healthcare sector. It has no operations and has no revenues.
545 West 25th Street
New York,
NY
10001
United States
Phone:
212 227 1905
Officers
Name | Title |
---|---|
Dr. Michael Shleifer Ph.D. | Chairman & CEO |
Mr. Thomas Fratacci | CFO & Treasurer |
Mr. Ivan Jarry | Chief Operating Officer |
Mr. Albert F. Hummel M.B.A. | Chief Investment Officer & Director |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
Forward PE: | 0 |
---|---|
Trailing PE: | 38.9808 |
Price-to-Book MRQ: | 1.3283 |
Price-to-Sales TTM: | 0 |
IPO Date: | 2021-03-22 |
Fiscal Year End: | December |
Full Time Employees: | 0 |